{"id":340904,"date":"2026-11-05T15:59:26","date_gmt":"2026-11-05T10:29:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-pat-387-crore\/"},"modified":"2026-11-05T15:59:26","modified_gmt":"2026-11-05T10:29:26","slug":"ipca-laboratories-q2-results-fy27-pat-387-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-pat-387-crore\/","title":{"rendered":"Ipca Laboratories Q2 Results FY27: Revenue Down 11.77% to Rs 2,255.61 Cr, PAT Up 37.06% to Rs 387.29 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Ipca Laboratories Q2 Results FY27 were declared on 5 November 2026, with revenue of Rs 2,255.61 Cr, down 11.77% YoY from Rs 2,556.5 Cr. Net profit came in at Rs 387.29 Cr against Rs 282.57 Cr a year earlier, a rise of 37.06%. These quarterly results show YoY growth in net profit alongside lower revenue.<\/p>\n<\/div>\n

Ipca Laboratories Ltd<\/a> (IPCALAB) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. Revenue was Rs 2,255.61 Cr and PAT was Rs 387.29 Cr. The results date of 5 November 2026 puts Ipca Laboratories Q2 Results FY27 on record for the period, with the figures drawn from the latest filing.<\/p>\n

This Ipca Laboratories Q2 Results analysis covers financial highlights, business drivers, outlook and risks. The results analysis starts with the financial highlights below, then reads revenue and net profit against the same quarter of last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n